A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety

Omar Nadeem; Robert Redd; Laura V. Stampleman; Jeffrey V. Matous; Andrew J. Yee; Jeffrey A. Zonder; Andrew Kin; Jacalyn Rosenblatt; Mark Bustoros; Julia Prescott; Alexandra Savell; Kathleen Guimond; Erin Frey; Rachel Styles; Adrienne Bielawski; Cody J Boehner; Nang Kham Su; Adam S Sperling; Giada Bianchi; Jacob P. Laubach; Jorge J. Castillo; Nikhil C. Munshi; Kenneth C. Anderson; Paul G. Richardson; Lorenzo Trippa; Irene M. Ghobrial

doi:10.1182/BLOOD-2019-129103

A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety

Omar Nadeem
, Robert Redd
, Laura V. Stampleman
, Jeffrey V. Matous
, Andrew J. Yee
, Jeffrey A. Zonder
, Andrew Kin
, Jacalyn Rosenblatt
, Mark Bustoros
, Julia Prescott
, Alexandra Savell
, Kathleen Guimond
, Erin Frey
, Rachel Styles
, Adrienne Bielawski
, Cody J Boehner
, Nang Kham Su
, Adam S Sperling
, Giada Bianchi
, Jacob P. Laubach

Jorge J. Castillo, Nikhil C. Munshi, Kenneth C. Anderson, Paul G. Richardson, Lorenzo Trippa, Irene M. Ghobrial

Harvard University
Pacific Cancer Care, Monterey, CA
Colorado Blood Cancer Institute, Denver, CO
Karmanos Cancer Institute, Detroit, MI
Wayne State University
Beth Israel Deaconess Medical Center
Dana Corporation

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	134
DOIs	https://doi.org/10.1182/BLOOD-2019-129103
State	Published - Nov 13 2019
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1182/BLOOD-2019-129103License: Unspecified

Cite this

Nadeem, O., Redd, R., Stampleman, L. V., Matous, J. V., Yee, A. J., Zonder, J. A., Kin, A., Rosenblatt, J., Bustoros, M., Prescott, J., Savell, A., Guimond, K., Frey, E., Styles, R., Bielawski, A., Boehner, C. J., Su, N. K., Sperling, A. S., Bianchi, G., ... Ghobrial, I. M. (2019). A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety. Blood, 134. https://doi.org/10.1182/BLOOD-2019-129103

Nadeem, O, Redd, R, Stampleman, LV, Matous, JV, Yee, AJ, Zonder, JA, Kin, A, Rosenblatt, J, Bustoros, M, Prescott, J, Savell, A, Guimond, K, Frey, E, Styles, R, Bielawski, A, Boehner, CJ, Su, NK, Sperling, AS, Bianchi, G, Laubach, JP, Castillo, JJ, Munshi, NC, Anderson, KC, Richardson, PG, Trippa, L & Ghobrial, IM 2019, 'A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety', Blood, vol. 134. https://doi.org/10.1182/BLOOD-2019-129103

@article{bc3d44e781824f70b8fc8fecd99381aa,

title = "A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety",

author = "Omar Nadeem and Robert Redd and Stampleman, \{Laura V.\} and Matous, \{Jeffrey V.\} and Yee, \{Andrew J.\} and Zonder, \{Jeffrey A.\} and Andrew Kin and Jacalyn Rosenblatt and Mark Bustoros and Julia Prescott and Alexandra Savell and Kathleen Guimond and Erin Frey and Rachel Styles and Adrienne Bielawski and Boehner, \{Cody J\} and Su, \{Nang Kham\} and Sperling, \{Adam S\} and Giada Bianchi and Laubach, \{Jacob P.\} and Castillo, \{Jorge J.\} and Munshi, \{Nikhil C.\} and Anderson, \{Kenneth C.\} and Richardson, \{Paul G.\} and Lorenzo Trippa and Ghobrial, \{Irene M.\}",

note = "Omar Nadeem, Robert Redd, Laura V. Stampleman, Jeffrey V. Matous, Andrew J. Yee, Jeffrey A. Zonder, Andrew Kin, Jacalyn Rosenblatt, Mark Bustoros, MD, Julia Prescott, Alexandra Savell, Kathleen Guimond, Erin Frey, Rachel Styles, Adrienne Bielawski, Cody J Boehner, Nang Kham Su, Multiple Myeloma Research Foundation Multiple Myeloma Research Foundation, The Leukemia \& Lymphoma Society The Leukemia \& Lymphoma Society, BCRP Blood Cancer Research Partnership, Adam S Sperling, Giada Bianchi, Jacob P.",

year = "2019",

month = nov,

day = "13",

doi = "10.1182/BLOOD-2019-129103",

language = "American English",

volume = "134",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety

AU - Nadeem, Omar

AU - Redd, Robert

AU - Stampleman, Laura V.

AU - Matous, Jeffrey V.

AU - Yee, Andrew J.

AU - Zonder, Jeffrey A.

AU - Kin, Andrew

AU - Rosenblatt, Jacalyn

AU - Bustoros, Mark

AU - Prescott, Julia

AU - Savell, Alexandra

AU - Guimond, Kathleen

AU - Frey, Erin

AU - Styles, Rachel

AU - Bielawski, Adrienne

AU - Boehner, Cody J

AU - Su, Nang Kham

AU - Sperling, Adam S

AU - Bianchi, Giada

AU - Laubach, Jacob P.

AU - Castillo, Jorge J.

AU - Munshi, Nikhil C.

AU - Anderson, Kenneth C.

AU - Richardson, Paul G.

AU - Trippa, Lorenzo

AU - Ghobrial, Irene M.

N1 - Omar Nadeem, Robert Redd, Laura V. Stampleman, Jeffrey V. Matous, Andrew J. Yee, Jeffrey A. Zonder, Andrew Kin, Jacalyn Rosenblatt, Mark Bustoros, MD, Julia Prescott, Alexandra Savell, Kathleen Guimond, Erin Frey, Rachel Styles, Adrienne Bielawski, Cody J Boehner, Nang Kham Su, Multiple Myeloma Research Foundation Multiple Myeloma Research Foundation, The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society, BCRP Blood Cancer Research Partnership, Adam S Sperling, Giada Bianchi, Jacob P.

PY - 2019/11/13

Y1 - 2019/11/13

UR - https://ashpublications.org/blood/article/134/Supplement_1/1898/427698/A-Phase-II-Study-of-Daratumumab-in-Patients-with

U2 - 10.1182/BLOOD-2019-129103

DO - 10.1182/BLOOD-2019-129103

M3 - Article

VL - 134

JO - Blood

JF - Blood

ER -

A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety

Disciplines

Access to Document

Other files and links

Cite this